Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Pristimerin induces apoptosis in non-small cell lung cancer by targeting thioredoxin reductase

Pristimerin induces apoptosis in non-small cell lung cancer by targeting thioredoxin reductase

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

JAK1 inhibition and Anti-PD1 therapy enhance outcomes in advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Combination therapy shows great promise as a new strategy against advanced lung cancer

Evaluation of serum tumor markers as adjuncts in NSCLC management

Evaluation of serum tumor markers as adjuncts in NSCLC management

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Combining JAK inhibitors with checkpoint inhibitors improves cancer immunotherapy response

Study reveals why EGFR inhibitors fail in some non-smokers with lung cancer

Study reveals why EGFR inhibitors fail in some non-smokers with lung cancer

Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

Study reveals disparities in the delivery of cancer-related care at minority serving hospitals

Study reveals disparities in the delivery of cancer-related care at minority serving hospitals

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Study reveals cancer treatment disparities at minority-serving hospitals

Study reveals cancer treatment disparities at minority-serving hospitals

AI-based body composition analysis predicts lung cancer treatment outcomes

AI-based body composition analysis predicts lung cancer treatment outcomes

New AI model sets benchmark in digital pathology with superior cancer diagnostics

New AI model sets benchmark in digital pathology with superior cancer diagnostics

Two studies aim to fight cancer with artificial cells

Two studies aim to fight cancer with artificial cells

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

New trials show promise for immune checkpoint blockers in early-stage lung cancer

New trials show promise for immune checkpoint blockers in early-stage lung cancer

Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance

Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.